Trastuzumab as a preoperative monotherapy does not inhibit HER2 downstream signaling in HER2-positive breast cancer. [electronic resource]

By: Contributor(s): Publication details: Oncology letters Sep 2016Description: 2028-2032 p. digitalISSN:
  • 1792-1074
Online resources: In: Oncology letters vol. 12
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.